Sign in
4

Changes in Ownership

Amylyx Pharmaceuticals, Inc. Filed Acc 0000950170-24-061294

Director bought 5,000 shares at an average $1.89 ($9,436)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Quimi Daphne Director 2024-05-14 Purchase +2,750 $1.89 $5,184 2,750 D
Quimi Daphne Director 2024-05-15 Purchase +2,250 $1.89 $4,252 5,000 D
Open-market purchases · 5,000 sh · avg $1.89 · $9,436
Loading xslF345X05/ownership.xml…